The first in healthcare investments, Capital Royalty LP announced today the closure of Capital Royalty Partners II LP's second private equity fund round. It was able to meet its target and actually exceeded it.
In this round, it was able to accumulate US$805 million and the overall capital is projected to be overcome was US$1 billion together with credit fund facilities that will be accessible to the Fund.
Chairman and Founder of Capital Royalty, Charles Tate, stated, "The high level of investor demand for this fund reflects Capital Royalty's consistent performance and differentiated investment strategy. Our unique strategy provides our Funds with the most attractive risk-adjusted returns and current cash yields, while maintaining considerable downside protection and minimal correlation to other asset classes. Capital Royalty remains well positioned to meet the growing demand for alternative financing structures in the healthcare industry."
Capital Royalty was founded in 2003 and is the first company in the field of medical investment with an estimated asset of US$1.3 billion. Its headquarters is in Houston, Texas with offices at New York and Boulder, Colorado.
Join the Conversation